Article Sidebar

Submitted
2 November 2016
Accepted
2 November 2016
Published
2 November 2016
Download
PDF
Statistic
Read Counter : 974 Download : 1274

Main Article Content

Abstract

Dengue hemorrhagic fever is one infectious diseases that have high case fatality rate in Indonesia. The aim of this study was to descibe the antibody anti-dengue profile in dengue hemorrhagic fever patients at Dr. Soetomo Hospital Surabaya. This study was epidemiological descriptive study to aims prevalence primary and secondary infection of dengue hemorrhagic fever and its clinical appearances. This study used 85 samples by taking medical record data of IgM and IgG anti-dengue serologic test from Internal Medicine Department, Dr. Soetomo Hospital, Surabaya, between January to December 2010. The data were collected and analyzed in diagrams and tables. Result of this study showed 25 (29,4%) patients had positive IgM serologic test, 14 (16,4%) patients had positive IgG serologic test and 46 (54,2%) patients had positive IgM and IgG serologic test. In primary infections, the history of fever was 3.8±1.2 days; platelet counts 58,6±21,4/ml and bleeding sign 37% of 25 patients. In secondary infections, the history of fever was 4.28±1.15 days; platelet count was 44,17±24,2/ml and bleeding sign 52% of 60 patients. In conclusion, patients with secondary infection have higher prevalence than primary infection. Then in secondary infection had more severe clinical appearance than primary infection.

Keywords

dengue hemorrhagic fever antibody anti-dengue

Article Details

License

Copyright (c) 2016 Langgeng A Waskito, Paulus B Notopuro, Pepy Dwi Endraswari

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

  • Folia Medica Indonesiana is a scientific peer-reviewed article which freely available to be accessed, downloaded, and used for research purposes. Folia Medica Indonesiana (p-ISSN: 2541-1012; e-ISSN: 2528-2018) is licensed under a Creative Commons Attribution 4.0 International License. Manuscripts submitted to Folia Medica Indonesiana are published under the terms of the Creative Commons License. The terms of the license are:

    Attribution ” You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.

    NonCommercial ” You may not use the material for commercial purposes.

    ShareAlike ” If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original.

    No additional restrictions ” You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.

    You  are free to :

    Share ” copy and redistribute the material in any medium or format.

    Adapt ” remix, transform, and build upon the material.

How to Cite
Waskito, L. A., Notopuro, P. B., & Endraswari, P. D. (2016). ANTIBODY ANTI-DENGUE PROFILE IN DENGUE HEMORRHAGIC FEVER PATIENTS AT DR. SOETOMO HOSPITAL, SURABAYA. Folia Medica Indonesiana, 51(3), 173–176. https://doi.org/10.20473/fmi.v51i3.2830
Download Citation
Endnote/Zotero/Mendeley (RIS)
BibTeX

References

  1. Aryati, Soetjipto, Hariadhi S, Rantam FA, Soegijanto S. 2006. Profile serotype virus dengue di Indonesia tahun 2003–2005. Maj. Ked. Trop. Ind. (MKTI). 17(1): 72–80.
  2. Darmowandowo, Widodo (2006). Continuing Education Ilmu Kesehatan Anak ke-36, Kapita Selekta Ilmu Kesehatan Anak VI. Surabaya: SMF Ilmu Kesehatan Anak FK Unair–Dr. Soetomo Hospital Surabaya
  3. PAHO (2008). Number of reported cases of dengue and dengue hemorrhagic fever (DHF), Region of the Americas (by country and subregion). Washington, DC, Pan American Health Organization. Available from:h ttp://www.paho.org/english/ad/dpc/cd/dengue.htm
  4. Porrozzi R, Teva A, Amaral VF, Santos Da Costa MV, Grimaldi Jr G (2004). Cross-immunity experiments between different species or strains of Leishmania in rhesus macaques (Macaca mulatta). The American journal of tropical medicine and hygiene, 71 (3): 297–305
  5. Soegianto, S (2006). Patogenesa dan Perubahan Patofisiologi Infeksi Virus Dengue. Available from: http://www.pediatrik.com/buletin/20060220-8ma2gi-buletin.pdf. Accessed Mei 12, 2011.
  6. Vaughn, David (1997). Dengue in the Early Febrile Phase: Viremia and Antibody Responses. The Journal of Infectious Diseases, 176:322–30
  7. WHO (2009). Dengue Guidelines for Diagnostic, Treatment, Prevention and Control. WHO press, Jeneva
  8. Yamanaka, Atsushi, et al. (2011). Displacement of the Predominant Dengue Virus from Type 2 to Type 1 with a Subsequent Genotype Shift from IV to I in Surabaya, Indonesia 2008–2010. PLoS ONE 6(11): e27322. doi:10.1371/journal.pone.0027322